Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers
Overall radiation treatment time has long been recognized as an important factor in head and neck tumor control. The concern of tumor growth in waiting time either before starting radiotherapy or during treatment is substantial given its negative impact on clinical outcome. There is an overwhelming evidence that increasing the time to initiate treatment increases the tumor burden and worsens the prognosis. This effect is more pronounced especially in patients with an early stage cancer disease. Delay in treatment initiation is contributed by both health care- and patient-related factors. Health care-related factors include advancement in diagnostic modalities and transfer of patient to academic health care centers accompanied by delayed referrals and long-awaited appointments. Patient-related factors include delayed reporting time and socioeconomic factors. An efficient transition of care along with access of cancer care modalities to community health care centers will not only improve the quality of care in secondary health care centers but also help decrease the patient burden in tertiary centers. A quick and well-structured multidisciplinary appointment program is fundamental in shortening the time required for patient referrals, thus increasing the optimal survival time for Head and Neck cancer patients with early initiation of treatment.
KeywordsHead and neck cancers Time to treatment initiation Treatment package time Radiation treatment time Radiation therapy
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Klausen OG, Olofsson J, Rosengren B. [A long waiting time for radiotherapy. Not acceptable for patients with neoplasms]. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke 1989;109 (23):2324–5.Google Scholar
- 15.•• Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169–78. A large database study showing that prolonged time to treatment initiation is affecting survival in head and neck cancer patients, with more than 60 days being consistently detrimental.PubMedCrossRefGoogle Scholar
- 16.Bietendorf J. FDG PET reimbursement. J Nuclear Med Technol. 2004;32(1):33–8.Google Scholar
- 17.Cacicedo J, Fernandez I, Del Hoyo O, Dolado A, Gomez-Suarez J, Hortelano E, et al. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis. Eur J Nucl Med Mol Imaging. 2015;42(9):1378–89.PubMedCrossRefGoogle Scholar
- 18.Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, et al. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(7):1190–5.CrossRefGoogle Scholar
- 28.•• Sharma S, Bekelman J, Lin A, Lukens JN, Roman BR, Mitra N, et al. Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma. Oral Oncol. 2016;56:17–24. NCDB study demonstrating socioeconomic status, academic setting, high volume, and IMRT as factors associated with increased diagnosis to treatment interval, correlating with survival outcomes.PubMedPubMedCentralCrossRefGoogle Scholar
- 44.Naghavi AO, Echevarria MI, Grass GD, Strom TJ, Abuodeh YA, Ahmed KA, et al. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016.Google Scholar
- 47.Rosenthal DI, Mohamed ASR, Garden AS, Morrison WH, El-Naggar AK, Kamal M, et al. Final report of a prospective randomized trial to evaluate the dose-response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2017;98(5):1002-11.PubMedCrossRefGoogle Scholar
- 57.• Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. The impact of radiation treatment time on survival in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2016;96(5):967–75. A large database study showing prolonged treatment time in head and neck cancers is associated with worst overall survival, even with chemoradiation.PubMedPubMedCentralCrossRefGoogle Scholar